8YMG
BRD4-BD1 in complex with 7-[4-chloro-1-(tetrahydropyran-4-ylmethyl)imidazol-2-yl]-5-methyl-2-{[(2R)-2-methyl-4-methylsulfonyl-piperazin-1-yl]methyl}furo[3,2-c]pyridin-4-one
This is a non-PDB format compatible entry.
Summary for 8YMG
Entry DOI | 10.2210/pdb8ymg/pdb |
Descriptor | Bromodomain-containing protein 4, 7-[4-chloro-1-(tetrahydropyran-4-ylmethyl)imidazol-2-yl]-5-methyl-2-{[(2R)-2-methyl-4-methylsulfonyl-piperazin-1-yl]methyl}furo[3,2-c]pyridin-4-one (3 entities in total) |
Functional Keywords | brd4, epigenetic, signaling protein-inhibitor complex, signaling protein/inhibitor, signaling protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 1 |
Total formula weight | 15694.49 |
Authors | Sasaki, C.,Miyaguchi, I.,Hagihara, S.,Ishizawa, K.,Endo, J. (deposition date: 2024-03-09, release date: 2025-03-12) |
Primary citation | Hagihara, S.,Ishizawa, K.,Kikuchi, M.,Kawano, Y.,Nishidate, A.,Matsumoto, F.,Hashimoto, N.,Sasaki, C.,Miyaguchi, I.,Okada, O.,Akashi, T.,Nakayama, S.,Ogasawara, Y.,Endo, J. Discovery of a potent, orally available furopyridine derivative as a novel selective BET BD1 Inhibitor (Part 1). To Be Published, |
Experimental method | X-RAY DIFFRACTION (1.007 Å) |
Structure validation
Download full validation report
